Date updated:01-01-2008
No description available

-
NOVN
Novn - $0.00
- N/A
- $N/A
First up is Noven Pharmaceuticals (NOVN- On Thursday Noven announced that U.S. regulators tentatively approved its experimental drug, Stavzor, which treats bipolar disorder, epilepsy migraine headaches. Despite this major piece of positive news, Noven shares actually finished down on Thursday by 1.5%-- Near its 52-week and with a short position of 10%, $75MM in cash and $0 debt, Noven is poised to move much higher now that the FDA has hinted that it will approve its drug.

-
EMC
E M C Cp - $17.14
- +0.59%
- $17.20
Next up is EMC (EMC)—Which is down over 30% from its high in October of $25 a share. Despite its insanely cheap valuations compared with VMware (which it owns 86% of) there are some concerns regarding EMC’s financial services industry business. However, Oracle’s very bullish earnings two weeks ago is a big positive for the sector. Their strength from the financial services industry negates the concerns that Cisco Systems had previously reported. This can be directly extrapolated as a positive for EMC given the percentage of their business in that area. Last week EMC bought Document Sciences (DOCS) for $85 million dollars. EMC has $5.5 billion in total cash so this is a relatively small buy for them. Also, management has a proven track record as they bought VMware for $600 million in 2003; currently VMware is worth $35 billion. With a $2 billion buyback, double digit earnings growth since 2002 EMC is one of the cheapest going into earnings season.

-
TGT
Target Cp - $47.26
- -0.42%
- $47.92
Last week Bill Ackman said that his hedge fund owned 9.9% of TGT and that he started a special $2BB fund just for shares of TGT. After popping 4% higher on the news, shares finished the week flat. The market is letting you piggyback off Ackman.

-
HBIO
Harvard Bioscienc - $3.67
- +0.55%
- $3.65
A few weeks ago HBIO got a bid-- The scientific instruments maker rejected Skystone Advisors' offer to take the company private for $5 a share in cash, saying the offer undervalues the company and is not in the best interest of the shareholders because Harvard Bioscience. This seems like an intersting play.

-
NTRI
Nutrisystem Inc - $23.93
- +5.00%
- $23.00
With New Years right around the corner, many Americans #1 resolution will be to lose weight. With 60% of Americans technically considered obese vs their “ideal weight” this leads me to my NutriSystems (NTRI)-- NutriSystems has had major issues regarding its patient of its weight lose drug, the company has guided down multiple times and has a massive short position of almost 60% (20% higher than that of Dendreon, which appeared I wrote about back in June) Many hedge funds are betting against NutriSystems with valid cuase. However, the company just issued a $100 million dollar buyback, has $200 million in cash and $0 debt

-
YHOO
Yahoo! Inc. - $15.45
- +0.46%
- $15.58
Triggered by our 3x2 system, shares of Yahoo are trading at the lower range and may move higher in the near-term.

-
NLY
Annaly Capital Ma - $18.07
- -0.22%
- $18.26
NLY just upped its yield—This will force high yielding mutual funds to buy into NLY. On an operations point of view, NLY is best positioned to soak up all of the horrible mortgage paper at dirt cheap valuations.

-
TEX
Terex Cp - $19.73
- -2.81%
- $20.71
Pure play off MTW-- Shares started to rally the past week or so and could trade back to $70ish level
- ROCKET STOCKS FOR THE WEEK OF DECEMBER 31ST – JANUARY 4TH's Blog
- EMC Sets International Reorg; Tranfers $4B From...
- AOL: No Growth Years Through 2014, Barclays Ana...
- The Big 2011 Yahoo! Options Bet (YHOO)
- Why Doesn't the Revenues per Employee Ratio (R/...
- AMZN: Piper Bumps Target To $163; Ups Estimates...
- show all
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Top 5 Small-Cap Stocks: N...
- » Echo5Joker's Portfolio
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 24, 2009 Don’t dismiss dividends right now. While stocks may have made significant strides in the rally that’s taken hold of the m...
By Roberto Pedone Posted on Nov. 24, 2009 10 Terrific Dividend Stocks: This Barron’s article highlights 10 high-quality dividend-paying stocks for investors who’re ...
By Jonas Elmerraji Posted on Nov. 23, 2009 As well as broad-based indexes have performed in the last few months, Stockpickr's weekly Rocket Stocks list has managed to d...
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
A. A stronger dollar, reduction in
government debt, gold backing of the
dollar.
A. The only one I own : SLX,
too hard pick a winner out all of them
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more
These are some of the stocks mentioned on TheStreet.com TV recently. Click the URL below each stock to watch the videos. more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 24, 2009. more













Comments not available